News

Professor Wojciech Niedzwiedz is joining our Scientific Advisory Board

Date
January 12, 2023
No items found.

Professor Wojciech Niedzwiedz from the Institute of Cancer Research and one of the top leaders in the field, is joining our Scientific Advisory Board.

Welcome on board!

This is a very important moment for us, which will further strengthen our drug discovery expertise in the field of DNA Damage Response and beyond!

https://www.icr.ac.uk/our-research/researchers-and-teams/dr-wojciech-niedzwiedz

Professor Wojciech Niedzwiedz is joining our Scientific Advisory Board
January 12, 2023

You may also like

Distribution-based feature extraction from copy number and structural variants in whole-genome data

With entire genomes at hand, scientists can pinpoint DNA fragments responsible for different cancers and predict patient responses to cancer treatments. However, the sheer volume of whole-genome data makes it difficult to encode the characteristics of genomic variants as features for machine learning algorithms.

Krzysztof Bokiej is a speaker at Data Science Summit ML Edition

Krzysztof Bokiej - Head of Platform and Pipelines at MNM - is a speaker at the most important Machine Learning conference in Poland.

Professor Wojciech Niedzwiedz is joining our Scientific Advisory Board

Professor Wojciech Niedzwiedz from the Institute of Cancer Research and one of the top leaders in the field, is joining our Scientific Advisory Board.

MNM Bioscience eyes cancer drug target discovery based on its AI algorithms

MNM Bioscience began as a bioinformatics company that curates data and then builds artificial intelligence-based algorithms, but it is now looking to branch out into oncology drug target discovery.